BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7237443)

  • 1. Evidence for double replication of chromosomal DNA segments as a general consequence of DNA replication inhibition.
    Woodcock DM; Cooper IA
    Cancer Res; 1981 Jun; 41(6):2483-90. PubMed ID: 7237443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a new mechanism of cytotoxicity of 1-beta-D arabinofuranosylcytosine.
    Woodcock DM; Fox RM; Cooper IA
    Cancer Res; 1979 Apr; 39(4):1418-24. PubMed ID: 421225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between aberrant DNA replication and loss of cell viability in Chinese hamster ovary CHO-K1 cells.
    Woodcock DM; Adams JK; Cooper IA
    Cancer Res; 1982 Nov; 42(11):4744-52. PubMed ID: 7127310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the nucleoside analogues alpha-ara A, beta-ara A and beta-ara C on cell growth and repair of both potentially lethal damage and DNA double strand breaks in mammalian cells in culture.
    Iliakis G; Bryant PE
    Anticancer Res; 1983; 3(2):143-9. PubMed ID: 6847132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.
    White EL; Shaddix SC; Brockman RW; Bennett LL
    Cancer Res; 1982 Jun; 42(6):2260-4. PubMed ID: 7042080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of action of 9-beta-D-arabinofuranosyladenine on the synthesis of DNA, RNA, and protein in vivo and in vitro.
    Müller WE; Rohde HJ; Beyer R; Maidhof A; Lachmann M; Taschner H; Kahn RK
    Cancer Res; 1975 Aug; 35(8):2160-8. PubMed ID: 1149031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine.
    Kufe D; Herrick D; Crumpacker C; Schnipper L
    Cancer Res; 1984 Jan; 44(1):69-73. PubMed ID: 6317173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 1-beta-D-arabinofuranosylcytosine incorporation on eukaryotic DNA template function.
    Kufe DW; Munroe D; Herrick D; Egan E; Spriggs D
    Mol Pharmacol; 1984 Jul; 26(1):128-34. PubMed ID: 6431261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA strand breaks caused by inhibitors of DNA synthesis: 1-beta-D-arabinofuranosylcytosine and aphidicolin.
    Fram RJ; Kufe DW
    Cancer Res; 1982 Oct; 42(10):4050-3. PubMed ID: 6809309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of DNA synthesis by 1-beta-D-arabinofuranosylcytosine.
    Bremerskov V
    Biomedicine; 1975 May; 22(3):217-22. PubMed ID: 1174630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionizing radiation induces two forms of interphase chromosome breaks in Chinese hamster ovary cells that rejoin with different kinetics and show different sensitivity to treatment in hypertonic medium or beta-araA.
    Okayasu R; Iliakis G
    Radiat Res; 1993 Nov; 136(2):262-70. PubMed ID: 8248484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repair of DNA following incorporation of 1-beta-D-arabinofuranosylcytosine into herpes simplex virus type 1.
    Bubley GJ; Crumpacker CS; Schnipper LE
    Cancer Res; 1984 May; 44(5):1813-8. PubMed ID: 6324990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of cis-diamminedichloroplatinum(II) with 1-beta-D-arabinofuranosylcytosine in LoVo colon carcinoma cells.
    Fram RJ; Robichaud N; Bishov SD; Wilson JM
    Cancer Res; 1987 Jul; 47(13):3360-5. PubMed ID: 3107809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of the cytokinetic response of KHT tumors in vivo to 1-beta-D-arabinofuranosylcytosine.
    Pallavicini MG; Gray JW; Folstad LJ
    Cancer Res; 1982 Aug; 42(8):3125-31. PubMed ID: 7093956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ara-C affects formation of cancer cell DNA synthesome replication intermediates.
    Abdel-Aziz W; Jiang HY; Hickey RJ; Malkas LH
    Cancer Chemother Pharmacol; 2000; 45(4):312-9. PubMed ID: 10755320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-beta-D-arabinofuranosylcytosine-induced chromatid breakage: effect of inhibition of DNA synthesis.
    Benedict WF; Rucker N; Karon M
    J Natl Cancer Inst; 1975 Feb; 54(2):431-3. PubMed ID: 1167597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro model system that can differentiate the stages of DNA replication affected by anticancer agents.
    Abdel-Aziz W; Hickey RJ; Malkas LH
    Biochem Pharmacol; 2004 Jul; 68(1):11-21. PubMed ID: 15183113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to 9-beta-D-arabinofuranosyladenine in murine tumor cells.
    LePage GA
    Cancer Res; 1978 Aug; 38(8):2314-6. PubMed ID: 580902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to 9-beta-D-arabinofuranosyladenine in cultured leukemia L 1210 cells.
    Cass CE; Selner M; Phillips JR
    Cancer Res; 1983 Oct; 43(10):4791-8. PubMed ID: 6603904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of hepatitis B virus deoxyribonucleic acid polymerase by the 5'-triphosphates of 9-beta-D-arabinofuranosyladenine and 1-beta-D-arabinofuranosylcytosine.
    Hess G; Arnold W; Meyer zum Büschenfelde KH
    Antimicrob Agents Chemother; 1981 Jan; 19(1):44-50. PubMed ID: 6166246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.